Resultados de la búsqueda 21-30 of 11688 for B cell lymphomas

  1. Hematología - Ensayos clínicos

    To investigate the efficacy of autologous Epstein-barr virus (EBV)-specific T cells for the treatment of EBV positive Diffuse Large B Cell Lymphoma (DLBCL), ...

  2. Linfoma difuso de linfocitos B grandes - Médicos y departamentos - Mayo Clinic

    Investigación. Mayo Clinic doctors and researchers are studying diffuse large B-cell lymphoma to look for new ...

  3. Hematología - Ensayos clínicos - Mayo Clinic

    ... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    ... b-cell lymphoma (DLBCL) patients with out of ... cells to recognize B cell specific tumor markers ... cell would result in T cell cytotoxic killing.

  6. Ensayos clínicos - Hematología

    ... B-Cell Lymphoma (DLBCL). A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy ...

  7. Linfoma difuso de linfocitos B grandes - Médicos y departamentos - Mayo Clinic

    Investigación. Mayo Clinic doctors and researchers are studying diffuse large B-cell lymphoma to ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...

  9. Hematología - Ensayos clínicos - Mayo Clinic

    ... Lymphoma (SLL). Rochester, Minn ... b-cell lymphoma (DLBCL) patients with out of ... cells by blocking some of the enzymes needed for cell growth ...

  10. Ensayos clínicos - Hematología

    Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas. Rochester, Minn. This is a Phase 1b ...